Ovarian stimulation in cancer patient

Abstract

Ovarian stimulation in cancer patients is a relatively new and challenging concept. A large number of cancer patients in the reproductive-age group are now expected to survive and lead a normal life. However, various therapies responsible for this markedly improved prognosis can also cause a significant detrimental effect on the reproductive ability. It is important that all young patients diagnosed with cancer are fully informed and offered the option of various fertility preservation strategies. Ovarian stimulation followed by either embryo or mature oocyte cryopreservation is currently the most successful option. Special considerations are required while performing ovarian stimulation in cancer patients. A detailed pretreatment assessment, counseling, and proper selection of ovarian stimulation protocol within the available short time period with minimum side effects are crucial to maximize the success of fertility preservation.